Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats

Background and objective: All-trans retinoic acid (ATRA), a promising therapeutic agent, has been confirmed in animal experiments as playing a protective role against renal diseases. The renin-angiotensin aldosterone system (RAAS) plays a key role in the pathogenesis of renal diseases, and RAAS inhi...

Full description

Bibliographic Details
Main Authors: Tian-Biao Zhou, Wei-Feng Wu, Yuan-Han Qin, Sheng-Sheng Yin
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2013-12-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320312465220
id doaj-6c617a0a452a45009936e207019d12e4
record_format Article
spelling doaj-6c617a0a452a45009936e207019d12e42021-05-02T14:43:56ZengHindawi - SAGE PublishingJournal of the Renin-Angiotensin-Aldosterone System1470-32031752-89762013-12-011410.1177/1470320312465220Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis ratsTian-Biao Zhou0Wei-Feng Wu1Yuan-Han Qin2Sheng-Sheng Yin3 Department of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, Guangxi, China Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China Department of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, Guangxi, China Department of Pediatric Nephrology, The First Affiliated Hospital of GuangXi Medical University, Nanning, Guangxi, ChinaBackground and objective: All-trans retinoic acid (ATRA), a promising therapeutic agent, has been confirmed in animal experiments as playing a protective role against renal diseases. The renin-angiotensin aldosterone system (RAAS) plays a key role in the pathogenesis of renal diseases, and RAAS inhibitors can prevent the progression of kidney diseases. In our previous study, we found that ATRA could play a protective role against glomerulosclerosis (GS) lesions in rats, and its effect was similar to RAAS inhibitors. However, whether ATRA treatment was associated with RAAS expression was not clear. Methods: Six-week-old male Wistar rats were divided into three groups: sham operation group (SHO), glomerulosclerosis model group without treatment (GS) and GS model group treated with ATRA (GA). At the end of 13 weeks, the relevant samples were collected and analyzed. Results: The mRNA and protein expression of angiotensin-converting enzyme 1 (ACE1) in the GS group was notably higher when compared with the SHO group. However, mRNA and protein expression of ACE1 in the ATRA treatment group was markedly down-regulated when compared with the GS group. Angiotensin-converting enzyme 2 (ACE2) expression (mRNA or protein) in the GS group was reduced compared with that in the SHO group, and ATRA markedly increased the mRNA and protein expression of ACE2 compared with the GS group. The levels of protein expression of angiotensin I and angiotensin II were significantly up-regulated in the GS group compared with those in the SHO group, and ATRA reduced their expression in the GA group when compared with the GS group. Conclusion: ATRA is associated with RAAS expression in GS rats, but its detailed mechanism needs to be elucidated by further research.https://doi.org/10.1177/1470320312465220
collection DOAJ
language English
format Article
sources DOAJ
author Tian-Biao Zhou
Wei-Feng Wu
Yuan-Han Qin
Sheng-Sheng Yin
spellingShingle Tian-Biao Zhou
Wei-Feng Wu
Yuan-Han Qin
Sheng-Sheng Yin
Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
Journal of the Renin-Angiotensin-Aldosterone System
author_facet Tian-Biao Zhou
Wei-Feng Wu
Yuan-Han Qin
Sheng-Sheng Yin
author_sort Tian-Biao Zhou
title Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
title_short Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
title_full Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
title_fullStr Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
title_full_unstemmed Association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
title_sort association of all-trans retinoic acid treatment with the renin-angiotensin aldosterone system expression in glomerulosclerosis rats
publisher Hindawi - SAGE Publishing
series Journal of the Renin-Angiotensin-Aldosterone System
issn 1470-3203
1752-8976
publishDate 2013-12-01
description Background and objective: All-trans retinoic acid (ATRA), a promising therapeutic agent, has been confirmed in animal experiments as playing a protective role against renal diseases. The renin-angiotensin aldosterone system (RAAS) plays a key role in the pathogenesis of renal diseases, and RAAS inhibitors can prevent the progression of kidney diseases. In our previous study, we found that ATRA could play a protective role against glomerulosclerosis (GS) lesions in rats, and its effect was similar to RAAS inhibitors. However, whether ATRA treatment was associated with RAAS expression was not clear. Methods: Six-week-old male Wistar rats were divided into three groups: sham operation group (SHO), glomerulosclerosis model group without treatment (GS) and GS model group treated with ATRA (GA). At the end of 13 weeks, the relevant samples were collected and analyzed. Results: The mRNA and protein expression of angiotensin-converting enzyme 1 (ACE1) in the GS group was notably higher when compared with the SHO group. However, mRNA and protein expression of ACE1 in the ATRA treatment group was markedly down-regulated when compared with the GS group. Angiotensin-converting enzyme 2 (ACE2) expression (mRNA or protein) in the GS group was reduced compared with that in the SHO group, and ATRA markedly increased the mRNA and protein expression of ACE2 compared with the GS group. The levels of protein expression of angiotensin I and angiotensin II were significantly up-regulated in the GS group compared with those in the SHO group, and ATRA reduced their expression in the GA group when compared with the GS group. Conclusion: ATRA is associated with RAAS expression in GS rats, but its detailed mechanism needs to be elucidated by further research.
url https://doi.org/10.1177/1470320312465220
work_keys_str_mv AT tianbiaozhou associationofalltransretinoicacidtreatmentwiththereninangiotensinaldosteronesystemexpressioninglomerulosclerosisrats
AT weifengwu associationofalltransretinoicacidtreatmentwiththereninangiotensinaldosteronesystemexpressioninglomerulosclerosisrats
AT yuanhanqin associationofalltransretinoicacidtreatmentwiththereninangiotensinaldosteronesystemexpressioninglomerulosclerosisrats
AT shengshengyin associationofalltransretinoicacidtreatmentwiththereninangiotensinaldosteronesystemexpressioninglomerulosclerosisrats
_version_ 1721490535734050816